nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—sarcoma	0.905	1	CbGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—FLI1—sarcoma	0.00918	0.239	CbGpPWpGaD
Framycetin—CXCR4—endothelium—sarcoma	0.00627	0.137	CbGeAlD
Framycetin—CXCR4—mammary gland—sarcoma	0.00506	0.111	CbGeAlD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—CSF3—sarcoma	0.00434	0.113	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—FLT1—sarcoma	0.00383	0.0996	CbGpPWpGaD
Framycetin—CXCR4—myometrium—sarcoma	0.00359	0.0785	CbGeAlD
Framycetin—CXCR4—embryo—sarcoma	0.00345	0.0755	CbGeAlD
Framycetin—CXCR4—seminal vesicle—sarcoma	0.00324	0.0709	CbGeAlD
Framycetin—CXCR4—hematopoietic system—sarcoma	0.00308	0.0674	CbGeAlD
Framycetin—CXCR4—connective tissue—sarcoma	0.00297	0.0649	CbGeAlD
Framycetin—CXCR4—smooth muscle tissue—sarcoma	0.00271	0.0593	CbGeAlD
Framycetin—CXCR4—S1P3 pathway—PDGFRB—sarcoma	0.00267	0.0693	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00236	0.0613	CbGpPWpGaD
Framycetin—CXCR4—cardiac atrium—sarcoma	0.00234	0.0512	CbGeAlD
Framycetin—CXCR4—uterus—sarcoma	0.00233	0.0509	CbGeAlD
Framycetin—CXCR4—lymphoid tissue—sarcoma	0.00217	0.0474	CbGeAlD
Framycetin—Ototoxicity—Thiotepa—sarcoma	0.00212	0.193	CcSEcCtD
Framycetin—CXCR4—tendon—sarcoma	0.00204	0.0446	CbGeAlD
Framycetin—CXCR4—bone marrow—sarcoma	0.00197	0.0432	CbGeAlD
Framycetin—CXCR4—testis—sarcoma	0.00169	0.0369	CbGeAlD
Framycetin—CXCR4—liver—sarcoma	0.0016	0.0349	CbGeAlD
Framycetin—CXCR4—CXCR4-mediated signaling events—PTPRC—sarcoma	0.00146	0.0379	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	0.00144	0.0374	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—SRC—sarcoma	0.00125	0.0325	CbGpPWpGaD
Framycetin—CXCR4—lymph node—sarcoma	0.00122	0.0268	CbGeAlD
Framycetin—CXCR4—S1P3 pathway—VEGFA—sarcoma	0.00122	0.0317	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KDR—sarcoma	0.00121	0.0315	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KIT—sarcoma	0.00112	0.029	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—FOXO1—sarcoma	0.00101	0.0263	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—NPM1—sarcoma	0.000912	0.0237	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000891	0.0232	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000641	0.0167	CbGpPWpGaD
Framycetin—Nephropathy toxic—Mitoxantrone—sarcoma	0.000639	0.0582	CcSEcCtD
Framycetin—Secondary infection—Epirubicin—sarcoma	0.000582	0.053	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.00056	0.0146	CbGpPWpGaD
Framycetin—Secondary infection—Doxorubicin—sarcoma	0.000538	0.049	CcSEcCtD
Framycetin—Nephropathy toxic—Etoposide—sarcoma	0.000531	0.0484	CcSEcCtD
Framycetin—Sensitisation—Epirubicin—sarcoma	0.000479	0.0436	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—SRC—sarcoma	0.000474	0.0123	CbGpPWpGaD
Framycetin—Sensitisation—Doxorubicin—sarcoma	0.000443	0.0404	CcSEcCtD
Framycetin—Viral infection—Mitoxantrone—sarcoma	0.000406	0.037	CcSEcCtD
Framycetin—Swelling—Mitoxantrone—sarcoma	0.000302	0.0275	CcSEcCtD
Framycetin—Swelling—Etoposide—sarcoma	0.000251	0.0229	CcSEcCtD
Framycetin—CXCR4—Disease—TLE1—sarcoma	0.000248	0.00644	CbGpPWpGaD
Framycetin—CXCR4—Disease—NPM1—sarcoma	0.000224	0.00581	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO2—sarcoma	0.000194	0.00504	CbGpPWpGaD
Framycetin—Viral infection—Epirubicin—sarcoma	0.000189	0.0172	CcSEcCtD
Framycetin—Erythema—Thiotepa—sarcoma	0.000186	0.0169	CcSEcCtD
Framycetin—Erythema—Dactinomycin—sarcoma	0.000184	0.0168	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—sarcoma	0.000175	0.016	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TLE1—sarcoma	0.000174	0.00451	CbGpPWpGaD
Framycetin—CXCR4—Disease—PLCG1—sarcoma	0.000164	0.00427	CbGpPWpGaD
Framycetin—Erythema—Mitoxantrone—sarcoma	0.00016	0.0146	CcSEcCtD
Framycetin—Infection—Thiotepa—sarcoma	0.000151	0.0137	CcSEcCtD
Framycetin—Infection—Dactinomycin—sarcoma	0.000149	0.0136	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—VEGFC—sarcoma	0.000146	0.00381	CbGpPWpGaD
Framycetin—Anaphylactic shock—Vincristine—sarcoma	0.000134	0.0122	CcSEcCtD
Framycetin—Infection—Vincristine—sarcoma	0.000134	0.0122	CcSEcCtD
Framycetin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000131	0.0119	CcSEcCtD
Framycetin—Infection—Mitoxantrone—sarcoma	0.00013	0.0118	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—FLT1—sarcoma	0.000117	0.00304	CbGpPWpGaD
Framycetin—CXCR4—Disease—FOXO1—sarcoma	0.000117	0.00303	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFRB—sarcoma	0.000116	0.00303	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLCG1—sarcoma	0.000115	0.00299	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFRA—sarcoma	0.000115	0.00298	CbGpPWpGaD
Framycetin—Hypersensitivity—Thiotepa—sarcoma	0.000112	0.0102	CcSEcCtD
Framycetin—Hypersensitivity—Dactinomycin—sarcoma	0.000111	0.0101	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—ATF1—sarcoma	0.000109	0.00284	CbGpPWpGaD
Framycetin—Anaphylactic shock—Etoposide—sarcoma	0.000109	0.00992	CcSEcCtD
Framycetin—Infection—Etoposide—sarcoma	0.000108	0.00985	CcSEcCtD
Framycetin—Pruritus—Thiotepa—sarcoma	0.000107	0.00977	CcSEcCtD
Framycetin—Diarrhoea—Thiotepa—sarcoma	0.000104	0.00945	CcSEcCtD
Framycetin—Diarrhoea—Dactinomycin—sarcoma	0.000103	0.00937	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CREB1—sarcoma	0.0001	0.00261	CbGpPWpGaD
Framycetin—Hypersensitivity—Vincristine—sarcoma	9.9e-05	0.00902	CcSEcCtD
Framycetin—Hypersensitivity—Mitoxantrone—sarcoma	9.64e-05	0.00878	CcSEcCtD
Framycetin—Vomiting—Thiotepa—sarcoma	9.64e-05	0.00878	CcSEcCtD
Framycetin—Vomiting—Dactinomycin—sarcoma	9.56e-05	0.00871	CcSEcCtD
Framycetin—Diarrhoea—Vincristine—sarcoma	9.2e-05	0.00838	CcSEcCtD
Framycetin—Nausea—Thiotepa—sarcoma	9e-05	0.0082	CcSEcCtD
Framycetin—Diarrhoea—Mitoxantrone—sarcoma	8.95e-05	0.00816	CcSEcCtD
Framycetin—Nausea—Dactinomycin—sarcoma	8.93e-05	0.00814	CcSEcCtD
Framycetin—CXCR4—Disease—KIT—sarcoma	8.88e-05	0.00231	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1R—sarcoma	8.58e-05	0.00223	CbGpPWpGaD
Framycetin—Vomiting—Vincristine—sarcoma	8.54e-05	0.00778	CcSEcCtD
Framycetin—CXCR4—Disease—CREB1—sarcoma	8.46e-05	0.0022	CbGpPWpGaD
Framycetin—Vomiting—Mitoxantrone—sarcoma	8.32e-05	0.00758	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—FOXO1—sarcoma	8.16e-05	0.00212	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—sarcoma	8.16e-05	0.00212	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFRB—sarcoma	8.15e-05	0.00212	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFRA—sarcoma	8.02e-05	0.00209	CbGpPWpGaD
Framycetin—Hypersensitivity—Etoposide—sarcoma	8.02e-05	0.00731	CcSEcCtD
Framycetin—Nausea—Vincristine—sarcoma	7.98e-05	0.00727	CcSEcCtD
Framycetin—Nausea—Mitoxantrone—sarcoma	7.77e-05	0.00708	CcSEcCtD
Framycetin—Pruritus—Etoposide—sarcoma	7.7e-05	0.00702	CcSEcCtD
Framycetin—Erythema—Epirubicin—sarcoma	7.48e-05	0.00681	CcSEcCtD
Framycetin—Diarrhoea—Etoposide—sarcoma	7.45e-05	0.00678	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—IL2—sarcoma	7.41e-05	0.00193	CbGpPWpGaD
Framycetin—CXCR4—Disease—MDM2—sarcoma	7e-05	0.00182	CbGpPWpGaD
Framycetin—Vomiting—Etoposide—sarcoma	6.92e-05	0.0063	CcSEcCtD
Framycetin—Erythema—Doxorubicin—sarcoma	6.92e-05	0.0063	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—KDR—sarcoma	6.75e-05	0.00176	CbGpPWpGaD
Framycetin—Nausea—Etoposide—sarcoma	6.47e-05	0.00589	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—KIT—sarcoma	6.22e-05	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—sarcoma	6.22e-05	0.00162	CbGpPWpGaD
Framycetin—Anaphylactic shock—Epirubicin—sarcoma	6.1e-05	0.00556	CcSEcCtD
Framycetin—Infection—Epirubicin—sarcoma	6.06e-05	0.00552	CcSEcCtD
Framycetin—CXCR4—Disease—CTNNB1—sarcoma	6.04e-05	0.00157	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CREB1—sarcoma	5.92e-05	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—sarcoma	5.67e-05	0.00147	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—sarcoma	5.65e-05	0.00514	CcSEcCtD
Framycetin—Infection—Doxorubicin—sarcoma	5.61e-05	0.00511	CcSEcCtD
Framycetin—CXCR4—Disease—SRC—sarcoma	5.46e-05	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—sarcoma	5.35e-05	0.00139	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—sarcoma	5.25e-05	0.00136	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MDM2—sarcoma	4.9e-05	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—sarcoma	4.89e-05	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—sarcoma	4.78e-05	0.00124	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—sarcoma	4.55e-05	0.00118	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—sarcoma	4.52e-05	0.00117	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—sarcoma	4.5e-05	0.0041	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—IL2—sarcoma	4.38e-05	0.00114	CbGpPWpGaD
Framycetin—Pruritus—Epirubicin—sarcoma	4.32e-05	0.00393	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCND1—sarcoma	4.27e-05	0.00111	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—sarcoma	4.26e-05	0.00111	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—sarcoma	4.23e-05	0.0011	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—sarcoma	4.18e-05	0.0038	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—sarcoma	4.16e-05	0.00379	CcSEcCtD
Framycetin—Pruritus—Doxorubicin—sarcoma	3.99e-05	0.00364	CcSEcCtD
Framycetin—Vomiting—Epirubicin—sarcoma	3.88e-05	0.00353	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—sarcoma	3.86e-05	0.00352	CcSEcCtD
Framycetin—CXCR4—Disease—HRAS—sarcoma	3.84e-05	0.000998	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—sarcoma	3.82e-05	0.000993	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—sarcoma	3.72e-05	0.000967	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—sarcoma	3.67e-05	0.000956	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—sarcoma	3.62e-05	0.0033	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—sarcoma	3.59e-05	0.00327	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—MYC—sarcoma	3.42e-05	0.00089	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—sarcoma	3.35e-05	0.00305	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—EGFR—sarcoma	3.35e-05	0.000871	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—sarcoma	3.16e-05	0.000822	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—sarcoma	2.81e-05	0.000731	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—sarcoma	2.69e-05	0.000699	CbGpPWpGaD
